Rémi Quirion
Douglas Mental Health University Institute
520 Papers
11.5K Citations
Rémi Quirion is an academic researcher from Douglas Mental Health University Institute. The author has contributed to research in topics: Receptor & Neuropeptide Y receptor. The author has an hindex of 101, co-authored 516 publications. Previous affiliations of Rémi Quirion include McGill University & La Salle University.
Chat about Author
Papers
Signaling Pathways Relevant to Cognition-Enhancing Drug Targets
TL;DR: This chapter summarizes the current understanding of how these signaling cascades could be modulated by cognition-enhancing agents favoring memory formation and successful aging and focuses on data obtained in rodents, particularly in the rat as it is the most common animal model studied in this field.
26
Coexistence of central and peripheral benzodiazepine binding sites in the human pineal gland
TL;DR: Results demonstrate, for the first time, the coexistence of peripheral and central benzodiazepine binding sites in the human pineal gland.
26
Central Administration of the Neurotensin Receptor Antagonist, SR48692, Modulates Diurnal and Stress-Related Hypothalamic-Pituitary-Adrenal Activity
W Rowe,Arnaud Nicot,Shakti Sharma,Danielle Gully,Claire-Dominique Walker,William Rostène,Michael J. Meaney,Rémi Quirion +7 more
TL;DR: Exogenous NT serves to increase HPA activity during periods of enhanced stimulation, suggesting that endogenous NT acts centrally to modulate adrenocorticotropin hormone and corticosterone release.
26
Neurotoxicity induced by interleukin-2: involvement of infiltrating immune cells.
TL;DR: The present study describes in detail the modifications in brain tissue architecture as they result in Sprague‐Dawley rats from intracerebroventricular administration of low amounts of IL‐2 and shows that chronic central administration of IL-2 led to T and B lymphocyte invasion of the brain and an intracranial agglomeration of large numbers of MHC class II‐positive cells.
25